Moody Lynn & Lieberson, LLC Neurocrine Biosciences Inc Transaction History
Moody Lynn & Lieberson, LLC
- $1.44 Billion
- Q1 2024
A detailed history of Moody Lynn & Lieberson, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Moody Lynn & Lieberson, LLC holds 22,428 shares of NBIX stock, worth $3.3 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
22,428Holding current value
$3.3 Million% of portfolio
0.21%Shares
8 transactions
Others Institutions Holding NBIX
# of Institutions
630Shares Held
94.4MCall Options Held
505KPut Options Held
343K-
Black Rock Inc. New York, NY13.8MShares$2.02 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.93MShares$1.46 Billion0.03% of portfolio
-
State Street Corp Boston, MA3.99MShares$587 Million0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY2.3MShares$338 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.25MShares$331 Million0.49% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $14.1B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...